Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature
- PMID: 27212418
- DOI: 10.1016/j.pediatrneurol.2016.03.003
Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature
Abstract
Background: The first sign of neurofibromatosis type 1 (NF1) in a child is often the presence of multiple café-au-lait macules. Although previous studies reported that almost individuals with multiple café-au-lait macules will eventually develop NF1 based on clinical criteria, recent studies and clinical observations suggest that a significant percentage of them do not have NF1.
Methods: We conducted the first systematic review of the literature on the prevalence of definitive NF1 among patients referred for isolated café-au-lait macules, searching more precisely for the proportion of those patients who do not have NF1. Because we now know that the presence of café-au-lait macules and freckling might not distinguish between NF1 and other conditions such as Legius syndrome, definitive NF1 was defined as the presence of café-au-lait macules with or without freckling plus one of the following: Lisch nodules, neurofibroma, plexiform neurofibroma, bone dysplasia, optic pathway glioma, or familial history of NF1.
Results: Six articles reported sufficient data to meet our inclusion criteria. Grouping all studies together, we found that 19.5% to 57.1% of all patients with isolated café-au-lait macules did not have a diagnosis of NF1 after follow-up or genetic testing.
Conclusion: A significant portion of the patients presenting with isolated café-au-lait macules at initial consultation might not have NF1. Genetic testing could help guide the follow-up of those patients, but further evidence is required to make recommendations.
Keywords: Recklinghausen disease; café-au-lait macules; children; clinical diagnosis; genetic testing; neurofibromatosis type 1.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.J Dermatol. 2016 May;43(5):537-42. doi: 10.1111/1346-8138.13169. Epub 2015 Oct 13. J Dermatol. 2016. PMID: 26458495
-
Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey.Childs Nerv Syst. 2024 Feb;40(2):511-515. doi: 10.1007/s00381-023-06061-5. Epub 2023 Jul 4. Childs Nerv Syst. 2024. PMID: 37401974
-
Significance of the Absence of Focal Areas of Signal Intensity on Brain Magnetic Resonance Imaging Examinations in Legius Syndrome.Pediatr Neurol. 2025 Aug;169:142-147. doi: 10.1016/j.pediatrneurol.2025.05.008. Epub 2025 May 12. Pediatr Neurol. 2025. PMID: 40516232
-
Pathogenesis and treatment of a giant occipital bone defect with meningoencephalocele in an NF1 child: case report and review of the literature.Childs Nerv Syst. 2024 Jan;40(1):27-39. doi: 10.1007/s00381-023-06232-4. Epub 2023 Nov 23. Childs Nerv Syst. 2024. PMID: 37993698
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.Hum Genet. 2022 Feb;141(2):177-191. doi: 10.1007/s00439-021-02410-z. Epub 2021 Dec 20. Hum Genet. 2022. PMID: 34928431 Free PMC article. Review.
-
Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.Ital J Pediatr. 2018 Apr 4;44(1):45. doi: 10.1186/s13052-018-0483-z. Ital J Pediatr. 2018. PMID: 29618358 Free PMC article.
-
The therapeutic potential of neurofibromin signaling pathways and binding partners.Commun Biol. 2023 Apr 20;6(1):436. doi: 10.1038/s42003-023-04815-0. Commun Biol. 2023. PMID: 37081086 Free PMC article. Review.
-
Genetic Analyses of the NF1 Gene in Turkish Neurofibromatosis Type I Patients and Definition of three Novel Variants.Balkan J Med Genet. 2017 Jun 30;20(1):13-20. doi: 10.1515/bjmg-2017-0008. eCollection 2017 Jun 30. Balkan J Med Genet. 2017. PMID: 28924536 Free PMC article.
-
[Pigmented macules as possible early signs of genetic syndromes].Hautarzt. 2019 Jul;70(7):506-513. doi: 10.1007/s00105-019-4416-6. Hautarzt. 2019. PMID: 31076812 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous